{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:56:02Z","timestamp":1773903362390,"version":"3.50.1"},"reference-count":23,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874212"],"award-info":[{"award-number":["81874212"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172653"],"award-info":[{"award-number":["82172653"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Creative Project for College Students","award":["S2021"],"award-info":[{"award-number":["S2021"]}]},{"name":"Huxiang High- Level Talent Innovation Team","award":["2018RS3072"],"award-info":[{"award-number":["2018RS3072"]}]},{"DOI":"10.13039\/501100019081","name":"Scientific and Technological Projects for Collaborative Prevention and Control of Birth Defect in Hunan Province","doi-asserted-by":"publisher","award":["2019SK1012"],"award-info":[{"award-number":["2019SK1012"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016104","name":"Key Grant of Research and Development in Hunan Province","doi-asserted-by":"publisher","award":["2020DK2002"],"award-info":[{"award-number":["2020DK2002"]}],"id":[{"id":"10.13039\/100016104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>In recent years, the anticancer effects of biguanide drugs have received considerable\nattention. However, the effective concentration of biguanide drugs to kill cancer cells is\nrelatively high. Thus, we focus on structural modification of biguanides to obtain better antitumor\ncandidates. A previous study in our laboratory has found that a biguanide compound containing the\nn-heptyl group has potent anticancer activity. However, the effect of different substituents on the\nbenzene ringside of the biguanides on the anti-proliferative activity is unknown.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>A series of n-heptyl-containing biguanide derivatives whose benzene rings were modified\nby halogen substitution based on the intermediate derivatization method were further synthesized to\nfind new compounds with improved antiproliferative activities.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>Ten n-heptyl-containing biguanide derivatives were synthesized via established chemical\nprocedures. The activities of these derivatives were explored by MTT assay, clonogenic assay, and\nscratch assay. The protein levels were detected via Western blotting to explore the underlying mechanisms.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The optimal biguanide derivatives 10a-10c, 11d exhibited IC50 values of 2.21-9.59 \u03bc\u039c for\nfive human cancer cell lines, significantly better than the control drug proguanil. The results of clonogenic\nand scratch wound healing assays also confirmed the inhibitory effects of derivatives 10a-\n10c, 11d on the proliferation and migration of human cancer cell lines. Western blot results demonstrated\nthat one representative derivative, 10c upregulates the AMPK signal pathway and downregulates\nmTOR\/4EBP1\/p70S6K.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>All biguanide derivatives containing n-heptyl groups are more active than proguanil,\nindicating that the modification of n-heptyl-containing biguanide derivatives provides a novel approach\nfor the development of novel high efficient antitumor drugs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406418666220210111458","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T11:57:45Z","timestamp":1644494265000},"page":"895-902","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Synthesis, Anticancer Activities, and Mechanism of N-heptyl-containing\nBiguanide Derivatives"],"prefix":"10.2174","volume":"18","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[{"name":"Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy,\nSchool of Medicine, Hunan Normal University, Changsha, Hunan, China"},{"name":"Changde Vocational Technical College, Changde, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Xiao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy,\nSchool of Medicine, Hunan Normal University, Changsha, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sichun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy,\nSchool of Medicine, Hunan Normal University, Changsha, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy,\nSchool of Medicine, Hunan Normal University, Changsha, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Tang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy,\nSchool of Medicine, Hunan Normal University, Changsha, Hunan, China"},{"name":"School of Food and Chemical Engineering, Shaoyang University, Shaoyang Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinchong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy,\nSchool of Medicine, Hunan Normal University, Changsha, Hunan, China"},{"name":"School of Food and Chemical Engineering, Shaoyang University, Shaoyang Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbing","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy,\nSchool of Medicine, Hunan Normal University, Changsha, Hunan, China"},{"name":"School of Food and Chemical Engineering, Shaoyang University, Shaoyang Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cangcang","family":"Xu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy,\nSchool of Medicine, Hunan Normal University, Changsha, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Peng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy,\nSchool of Medicine, Hunan Normal University, Changsha, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, Department of Pharmacy,\nSchool of Medicine, Hunan Normal University, Changsha, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1021\/acs.inorgchem.9b03093","volume":"59","author":"Dehmel M.","year":"2020","unstructured":"Dehmel M.; Vass V.; Prock L.; G\u00f6rls H.; Kretschmer R.; Synthesis and coordination chemistry of 3,4-ethylene-bridged 1,1,2,5-tetrasubstituted biguanides. Inorg Chem 2020,59(5),2733-2746","journal-title":"Inorg Chem"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/eurjpc\/zwaa157","volume":"28","author":"Aboyans V.","year":"2021","unstructured":"Aboyans V.; Sattar N.; Type-2 diabetes patients at high risk for cardiovascular events: Time to challenge the \u2018metformin-always first\u2019 paradigm. Eur J Prev Cardiol 2021,28(1),66-68","journal-title":"Eur J Prev Cardiol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/1440-1681.13302","volume":"47","author":"Chen D.","year":"2020","unstructured":"Chen D.; Jia D.; Wu X.; Shi K.; Ren C.; Dou Y.; Guo M.; Wang J.; Ma M.; Wu Z.; Shi H.Y.; Li W.; Feng Y.; Wu F.; A novel met-formin derivative showed improvement of lipid metabolism in obese rats with type 2 diabetes. Clin Exp Pharmacol Physiol 2020,47(8),1382-1392","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12933-020-01131-3","volume":"19","author":"Hansen C.S.","year":"2020","unstructured":"Hansen C.S.; Lundby-Christiansen L.; Tarnow L.; Gluud C.; Hedetoft C.; Thorsteinsson B.; Hemmingsen B.; Wiinberg N.; Sneppen S.B.; Lund S.S.; Krarup T.; Madsbad S.; Almdal T.; Carstensen B.; J\u00f8rgensen M.E.; CIMT study group. Metformin may adversely af-fect orthostatic blood pressure recovery in patients with type 2 diabetes: Substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial. Cardiovasc Diabetol 2020,19(1),150","journal-title":"Cardiovasc Diabetol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/cas.13849","volume":"110","author":"Deng J.","year":"2019","unstructured":"Deng J.; Peng M.; Wang Z.; Zhou S.; Xiao D.; Deng J.; Yang X.; Peng J.; Yang X.; Novel application of metformin combined with targeted drugs on anticancer treatment. Cancer Sci 2019,110(1),23-30","journal-title":"Cancer Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"114345","DOI":"10.1016\/j.bcp.2020.114345","volume":"183","author":"Bland A.R.","year":"2021","unstructured":"Bland A.R.; Shrestha N.; Bower R.L.; Rosengren R.J.; Ashton J.C.; The effect of metformin in EML4-ALK+ lung cancer alone and in combination with crizotinib in cell and rodent models. Biochem Pharmacol 2021,183,114345","journal-title":"Biochem Pharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41401-020-00508-0","volume":"41","author":"Ma R.","year":"2020","unstructured":"Ma R.; Yi B.; Riker A.I.; Xi Y.; Metformin and cancer immunity. Acta Pharmacol Sin 2020,41(11),1403-1409","journal-title":"Acta Pharmacol Sin"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"40767","DOI":"10.18632\/oncotarget.8194","volume":"7","author":"Chae Y.K.","year":"2016","unstructured":"Chae Y.K.; Arya A.; Malecek M.K.; Shin D.S.; Carneiro B.; Chandra S.; Kaplan J.; Kalyan A.; Altman J.K.; Platanias L.; Giles F.; Repurposing metformin for cancer treatment: Current clinical studies. Oncotarget 2016,7(26),40767-40780","journal-title":"Oncotarget"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"Liberati A.","year":"2009","unstructured":"Liberati A.; Altman D.G.; Tetzlaff J.; Mulrow C.; G\u00f8tzsche P.C.; Ioannidis J.P.; Clarke M.; Devereaux P.J.; Kleijnen J.; Moher D.; The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 2009,339,b2700","journal-title":"BMJ"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.21873\/anticanres.12819","volume":"38","author":"Lea M.A.","year":"2018","unstructured":"Lea M.A.; Kim H.; desBORDES, C. Effects of biguanides on growth and glycolysis of bladder and colon cancer cells. Anticancer Res 2018,38(9),5003-5011","journal-title":"Anticancer Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e1900075","DOI":"10.1002\/ardp.201900075","volume":"352","author":"Zhou S.","year":"2019","unstructured":"Zhou S.; Xu L.; Cao M.; Wang Z.; Xiao D.; Xu S.; Deng J.; Hu X.; He C.; Tao T.; Wang W.; Guan A.; Yang X.; Anticancer proper-ties of novel pyrazole-containing biguanide derivatives with activating the adenosine monophosphate-activated protein kinase signaling pathway. Arch Pharm (Weinheim) 2019,352(9),e1900075","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40880-018-0319-7","volume":"38","author":"Huang Y.","year":"2018","unstructured":"Huang Y.; Zhou S.; He C.; Deng J.; Tao T.; Su Q.; Darko K.O.; Peng M.; Yang X.; Phenformin alone or combined with gefitinib inhib-its bladder cancer via AMPK and EGFR pathways. Cancer Commun (Lond) 2018,38(1),50","journal-title":"Cancer Commun (Lond)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"9854","DOI":"10.1038\/s41598-021-87993-3","volume":"11","author":"H\u00e9bert A.","year":"2021","unstructured":"H\u00e9bert A.; Parisotto M.; Rowell M.C.; Dor\u00e9 A.; Fernandez Ruiz A.; Lefran\u00e7ois G.; Kalegari P.; Ferbeyre G.; Schmitzer A.R.; Phe-nylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth. Sci Rep 2021,11(1),9854","journal-title":"Sci Rep"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.trecan.2021.03.001","volume":"7","author":"Zhao H.","year":"2021","unstructured":"Zhao H.; Swanson K.D.; Zheng B.; Therapeutic repurposing of biguanides in cancer. Trends Cancer 2021,7(8),714-730","journal-title":"Trends Cancer"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"115258","DOI":"10.1016\/j.bmc.2019.115258","volume":"28","author":"Xiao D.","year":"2020","unstructured":"Xiao D.; Lu Z.; Wang Z.; Zhou S.; Cao M.; Deng J.; Hu X.; Peng M.; He C.; Wu J.; Xu S.; Zhang H.; Xu C.; Wang W.; Guan A.; Yang X.; Synthesis, biological evaluation and anti-proliferative mechanism of fluorine-containing proguanil derivatives. Bioorg Med Chem 2020,28(2),115258","journal-title":"Bioorg Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.3390\/molecules26195775","volume":"26","author":"Xu S.","year":"2021","unstructured":"Xu S.; Cao Y.; Luo Y.; Xiao D.; Wang W.; Wang Z.; Yang X.; Synthesis, anti-proliferative evaluation and mechanism of 4-trifluoro methoxy proguanil derivatives with various carbon chain length. Molecules 2021,26(19),5775","journal-title":"Molecules"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1021\/cr4005605","volume":"114","author":"Guan A.","year":"2014","unstructured":"Guan A.; Liu C.; Yang X.; Dekeyser M.; Application of the intermediate derivatization approach in agrochemical discovery. Chem Rev 2014,114(14),7079-7107","journal-title":"Chem Rev"},{"key":"ref=18","year":"2010","unstructured":"Sathe, D.G.; Mondkar, H.K.; Jadhav, T.S.; Hagavane, N.N. Process\nfor preparation of proguanil hydrochloride. EP Patent 2150528A2 2010"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ejmech.2016.09.051","volume":"125","author":"Loesche A.","year":"2017","unstructured":"Loesche A.; Wiese J.; Sommerwerk S.; Simon V.; Brandt W.; Csuk R.; Repurposing N.; Repurposing N.; N'-bis-(arylamidino)-1,4-piperazinedicarboxamidines: An unexpected class of potent inhibitors of cholinesterases. Eur J Med Chem 2017,125,430-434","journal-title":"Eur J Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3389\/fendo.2018.00522","volume":"9","author":"Cork G.K.","year":"2018","unstructured":"Cork G.K.; Thompson J.; Slawson C.; Real talk: The inter-play between the mTOR, AMPK, and hexosamine biosynthetic pathways in cell signaling. Front Endocrinol (Lausanne) 2018,9,522","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.biopha.2017.07.036","volume":"93","author":"Cao C.","year":"2017","unstructured":"Cao C.; Han D.; Su Y.; Ge Y.; Chen H.; Xu A.; Ginkgo biloba exocarp extracts induces autophagy in Lewis lung cancer cells involving AMPK\/mTOR\/p70S6k signaling pathway. Biomed Pharmacother 2017,93,1128-1135","journal-title":"Biomed Pharmacother"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1021\/acs.jafc.9b00170","volume":"67","author":"Wei Q.","year":"2019","unstructured":"Wei Q.; Zhang B.; Li P.; Wen X.; Yang J.; Maslinic acid inhibits colon tumorigenesis by the AMPK-mTOR signaling pathway. J Agric Food Chem 2019,67(15),4259-4272","journal-title":"J Agric Food Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.fct.2018.09.079","volume":"122","author":"Vazirian M.","year":"2018","unstructured":"Vazirian M.; Nabavi S.M.; Jafari S.; Manayi A.; Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities. Food Chem Toxicol 2018,122,69-79","journal-title":"Food Chem Toxicol"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220210111458","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/201002\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220210111458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T18:15:26Z","timestamp":1693160126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/201002\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406418666220210111458","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}